News from janssen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Jun 11, 2018, 03:00 ETJanssen to Showcase New Data Across Broad Rheumatology Portfolio and Immunology Pipeline at EULAR 2018

FOR MEDICAL AND TRADE ONLY The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that ten company-sponsored abstracts will be...


May 02, 2018, 07:00 ETJanssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a definitive...


Apr 03, 2018, 11:20 ETBrasil é primeiro país a aprovar antecipação de tratamento da Janssen para câncer no sangue

Os brasileiros com mieloma múltiplo recém-diagnosticados e que não podem realizar o transplante autólogo de células-tronco (quando o doador é o...


Mar 28, 2018, 03:33 ETNovo tratamento da Janssen para psoríase é aprovado no Brasil

A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou um medicamento inédito para psoríase, doença imunológica que atinge cerca de 5 milhões de ...


Feb 22, 2018, 06:00 ETCâncer de próstata: novo tratamento da Janssen reduz em 72% o risco de aparecimento de metástase ou morte

No Brasil, o câncer de próstata é o segundo mais comum entre os homens, atrás apenas do câncer de pele não-melanoma[i]. Apesar dos avanços no...


Dec 12, 2017, 08:30 ETEstudo com medicamento da Janssen mostra que é possível interceptar tipo de câncer de sangue antes do seu aparecimento

Interceptar o câncer antes do seu aparecimento, aumentar o tempo livre de progressão da doença e proporcionar tratamentos mais cômodos aos pacientes. ...


Dec 05, 2017, 12:32 ETJohnson & Johnson anuncia desenvolvimento de vacina contra o Zika

A Johnson & Johnson anuncia que a Janssen Vaccines & Prevention B.V., parte da Janssen Pharmaceutical Companies, está trabalhando em parceria com o...


Oct 30, 2017, 11:08 ETNew Data Show Symptom Improvement Within One Week for Patients with Moderately to Severely Active Crohn's Disease Treated With STELARA® (ustekinumab)

FOR MEDICAL AND TRADE MEDIA ONLY Late-breaking data demonstrate rapid improvement in patient-reported symptoms in patients intolerant or refractory...


Sep 16, 2017, 02:00 ETJanssen Research and Development, LLC: New Two-year Guselkumab Data Show Patients with Moderate to Severe Plaque Psoriasis Achieved Consistent Rates of Skin Clearance

More than 80 percent of patients receiving guselkumab, including patients transitioned from HUMIRA® (adalimumab) to the anti-interleukin (IL)-23...


Sep 15, 2017, 10:23 ETJanssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending ...


Sep 11, 2017, 01:24 ETJanssen to Discontinue Hepatitis C Development Program

Viral Hepatitis Research and Development to Focus on Addressing Significant Unmet Needs in Chronic Hepatitis B Janssen Sciences Ireland UC (Janssen), ...


Sep 06, 2017, 08:30 ETAprovado novo tratamento para doença de Crohn no Brasil

Uma nova terapia para a doença de Crohn acaba de ser aprovada no país pela Agência Nacional de Vigilância Sanitária (Anvisa). Ustequinumabe,...


Sep 04, 2017, 03:00 ETUna nueva investigación recomienda más diálogo sobre tratamientos entre psiquiatras y sus pacientes con esquizofrenia

Janssen ha anunciado los resultados de un estudio paneuropeo que concluye que un tercio de psiquiatras (34%) evita tener un dialogo abierto con sus...


Aug 27, 2017, 05:27 ETXARELTO® (rivaroxaban) Significantly Reduced Major Cardiovascular Events in Patients with Stable Coronary and Peripheral Artery Disease in Pivotal Phase 3 Study

Results from the pivotal Phase 3 COMPASS study found that the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin 100 mg once...


Jul 13, 2017, 16:00 ET"Investigaciones que hacen historia", un compromiso de la ciencia, para transformar la vida de los pacientes

Janssen, compañía farmacéutica de Johnson & Johnson, organiza el V Summit de Centroamérica y Caribe, evento de actualización médico - científica de...


Jun 08, 2017, 10:08 ETTratamentos da Janssen prolongam vida e reduzem risco de morte por câncer

Redução do risco de morte e mais tempo de vida para pacientes com câncer de próstata e controles mais duradouros da leucemia linfocítica crônica e do ...


Jun 01, 2017, 15:59 ETJanssen Announces Submissions in Europe and US for Single-Tablet Regimen of Dolutegravir plus Rilpivirine - the First Two-Drug HIV Maintenance Treatment

Janssen Sciences Ireland UC, today announced that ViiV Healthcare has made regulatory submissions to both the European Medicines Agency (EMA) and the ...


May 05, 2017, 08:30 ETNovo medicamento da Janssen reforça arsenal de tratamento contra mieloma múltiplo

Uma nova opção de tratamento para o mieloma múltiplo já está disponível para os brasileiros. Daratumumabe chega para responder a uma necessidade não...


Oct 10, 2016, 03:00 ETNuevo estudio destaca el papel crucial de los cuidadores de adultos con esquizofrenia

SOLO PARA COMERCIO DE LA UE Y MEDIOS MÉDICOS Nuevo estudio pan-europeo encargado por Janssen destaca la necesidad de más educación y diálogo abierto...


Oct 10, 2016, 03:00 ETNeue Umfrage unterstreicht die entscheidende Rolle von Pflegepersonen für erwachsene Schizophrenie-Patienten

NUR FÜR FACH- UND MEDIZINISCHE MEDIEN IN DER EU Eine neue gesamteuropäische Studie im Auftrag von Janssen unterstreicht den Bedarf an mehr Ausbildung ...


Oct 10, 2016, 03:00 ETUne nouvelle enquête met en relief le rôle crucial des soignants auprès des adultes atteints de schizophrénie

DESTINÉ UNIQUEMENT AUX REPRÉSENTANTS DES MÉDIAS MÉDICAUX ET COMMERCIAUX DE L'UNION EUROPÉENNE Une nouvelle enquête paneuropéenne commandée par...


Apr 18, 2016, 06:00 ETNew Data from U.S. Post-Approval Study Assess Ischemic Stroke and Intracranial Hemorrhage Rates in People with Non-Valvular Atrial Fibrillation Comparing Both Rivaroxaban with Warfarin and Apixaban with Warfarin

Results of the REVISIT-US study, an analysis including 30,988 patients that evaluated the real-world occurrence of ischemic stroke and intracranial...


Apr 02, 2016, 10:30 ETReal-World Study Further Confirms Safety Profile of XARELTO® in Nearly 45,000 People with Non-Valvular Atrial Fibrillation (NVAF), Including Those with Concomitant Diabetes

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of...


Dec 02, 2015, 09:05 ETCutting edge therapy for Psoriasis patients now available in the Caribbean

Psoriasis is a chronic skin disease that affects around 140 million people worldwide. It's more frequent between the ages of 15 and 25, but may...


Sep 14, 2015, 10:38 ETVerbeterd investeringsklimaat voor farmaceutische R&D zal bijdragen aan de aanpak van Europese vraagstukken over gezondheid en economie

Vervolgonderzoek bevestigt de groeiende economische en maatschappelijke waarde van investeringen in de R&D in de gezondheidssector. Dit kan alleen...